ALFA Finder| Revenue growth | Q2 revenue ~18.7x YoY (₹128.81 Cr vs ₹6.87 Cr) |
|---|---|
| Margins | Q2 EBITDA margin 2.09% vs -24.66%; H1 12.63% vs 27.54% |
| Demand visibility | H1 pre-sales ₹955 Cr, +69% YoY; end-user led |
| Management confidence | CEO: 'remain confident in our strategy' |
Growth
Q2 revenue ₹128.81 Cr vs ₹6.87 Cr. H1 revenue ₹345.94 Cr vs ₹82.77 Cr. H1 collections ₹462 Cr (+27% YoY).
Outlook
FY27 cashflow ₹1,600-1,800 Cr; ~₹10,000 Cr over 5 years. ~₹1,000 Cr Tripundra revenue recognition in FY27.
Risks
Q2 PBT loss ₹13.06 Cr; EBITDA margin 2.09%; finance costs up to ₹13.61 Cr; PAT aided by ₹17.46 Cr tax credit.
Investor Presentation filed with NSE, NSE: TARC. Summary written with AI assistance from the document.
TARC Ltd: key numbers
- Share price
- ₹133.44
- Market cap
- ₹3,938 Cr
- Revenue (annual)
- ₹329.8 Cr
- Net profit (annual)
- ₹19.07 Cr
- P/E (TTM)
- -314.8×Sector 38.0×
- Promoter holding
- 65.12%+0.00% QoQ
- FII holding
- 1.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TARC Ltd
All →TARC Results Update
TARC reported H1 FY2027 total income of ₹352.78 crore and PAT of ₹27 crore. Q2 PAT was ₹4.05 crore, versus a loss in Q2 FY2026.
TARC Q2 FY27 Results: Turns Profitable, Net Profit ₹4.4 Cr
TARC Ltd reported revenue from operations of ₹128.8 Cr (+1766.7% YoY) and net profit of ₹4.4 Cr for Q2 FY27.
- Key figure
- Net profit ₹4.4 Cr
TARC Management Change
TARC's independent director Ambarish Chatterjee completes his second and final term on 9 November 2026. The Board also reconstituted its committees effective 10 November 2026.
TARC Board Meeting Date
TARC Ltd intimated that its Board will meet on 5 Nov 2026. The agenda includes approving unaudited H1 FY27 financial results.
TARC Other Announcement
TARC Limited has filed its quarterly shareholding pattern for the period ending September 30, 2026, as per regulatory requirements.
TARC Annual General Meeting
TARC Limited conducted its 10th Annual General Meeting on September 19, 2026. The meeting covered financial statement adoption and director appointments alongside remuneration revisions.